Surgical Innovations in Gynecologic Cancers - 2020 Annual Meeting Webinar

Join the Society of Gynecologic Oncology for "Surgical Innovations in Gynecologic Cancer." This session includes plenary abstracts from the SGO 2020 Annual 

Meeting, moderated by Jamie Bakkum-Gamez and Kara Long Roche. 

 

 

 

 

 

JOINT ACCREDITATION
In support of improving patient care, the Society of Gynecologic Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team.

 

AMA Credit Designation Statement – Physicians
The Society of Gynecology Oncology designates this live activity for a maximum of 1.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation on each activity.

ANCC Credit Designation Statement – Nurses
This activity has been approved for a maximum of 1.25 nursing contact hours.

ACPE Credit Designation Statement – Pharmacists
Each activity has been approved for a maximum of 1.25 contact hours of pharmacy continuing education credit. UAN number JA0007238-0000-20-018-H01-T

PAs may claim a maximum of 1.25 AMA PRA Category 1 Credits™ for completing this live activity. NCCPA accepts AMA PRA Category 1 Credits™ from organizations accredited by ACCME or a recognized state or medical society.

 

In order to assure the highest quality CE programming, SGO requires those who have the opportunity to affect the content of an educational activity to disclose relevant financial relationship(s) with corporate interest(s). This condition must be met prior to participating in the CE activity. All relevant conflicts of interest will be resolved prior to the start of the activity, per the SGO Conflict of Interest Resolution Policy.

 

The following have indicated that no relevant conflicts(s) of interest exist:

Amanda Bruegl,MD
Tara Castellano, MD
Lauren Patterson Cobb, MD
Joshua Cohen, MD
Maria Cusimano, MD
Sarah Ferguson, MD
Whitfield Growdon, MD
Andrea Hagemann, MD
Jean M. Hansen, DO, MS
Emily Hinchcliff, MD
Charles "Chip" Landen, MD, MS
Carolyn Lefkowits, MD
Cara Mathews, MD
Tashanna Myers, MD
Ji Heum Paek, MD, PhD
Katie Pennington
Brandon Roane, MD
Kara Long Roche, MD
Emma Rossi, MD
Stephanie Sullivan, MD
Taylor Turner, MD
Kaylee Underkofler, MD, MPH, MS
Ate van Der Zee, PhDE
Susan L. Zweizig, MD

 

The following have reported a relevant relationship with a corporate interest, as listed, that may result in a conflict of interest:
All relevant conflict(s) of interest have been resolved through SGOs Conflict of Interest Resolution Policy.

Rebecca Arend, MD
Consulting: AstraZeneca, Tesaro, Clovis; Honoraria/Reimbursement :Leap Therapeutics;

Jamie Bakkum-Gamez, MD
IP disclosure of EC and OC DNA biomarker:s Exact Sciences 

Susana Banerjee, MBBS, MA, PhD, FRCP
Honoraria/Reimbursement: AstraZeneca, Tesaro, Clovis, Nucana, Roche, Merck Serono, Seattle Genetics

Melissa Geller, MD
Clinical trial: Genentech, Fate Therapeutics, Morphotek, Tesaro

Gonzalo Giornelli-Gomez, MD
Consulting: AstraZeneca, Merck Sharp and Dohme, Roche, Janssen Cilag

Camille Gunderson, MD
Advisory board: Agenus, Clovis, Cordgenics

Kenneth Kim, MD, MPHE
Grant: Grant; Consulting: Ethicon/Johnson & Johnson

Lisa Landrum, MD, PhD
Honoraria/Reimbursement: Carter Healthcare

Stephanie Lheureux, MD, PhD
Consulting: AstraZeneca, Merck, Roche, GSK; Honoraria/Reimbursement: AstraZeneca, Merck 

Kathleen Moore, MD
Consulting: Aravive, Oncomed, Immunogen, AstraZeneca; Honoraria/Reimbursement: Clovis, Genentech/Roche, Pfizer, VBL Therapeutics, Merck, Eisai, Tesaro, Immunogen, AstraZeneca

Bhavana Pothuri, MD, MS
Advisory board: Tesaro  Grant

Leslie Randall, MD
Board Membership: GOG Foundation; Consulting: GOG Foundation, TESARO, AstraZeneca, Merck; Grant: On Target Laboratories, Aivita Biomedical, TESARO, AstraZeneca, Merck; Honoraria/Reimbursement: GOG Foundation, TESARO, AstraZeneca, Merck; Speakers' Bureau(s): TESARO, AstraZeneca, Merck

Scott Richard, MD
Speakers' Bureau(s): Clovis Oncology, AstraZeneca

B.J. Rimel, MD
Consulting: Tesaro, Genentech, Deep6AI, Clovis, AstraZeneca

Leigha Senter-Jamieson, Allied (MS, LGC)
Consulting: AstraZeneca, Clovis Oncology; Speakers' Bureau(s): AstraZeneca

David Tan, MBBS, FRCP, PhD
Consulting: AstraZeneca, Roche, Bayer, MSD, Tessa Therapeutics, Genmab, Eisai; Grant: AstraZeneca, Roche, Bayer, Karyopharm Therapeutics; Honoraria/Reimbursement: AstraZeneca, Roche, Bayer, MSD, Tessa Therapeutics, Genmab, Eisai

Daniel Veljovich, MD
Consulting: Tesaro/GSK, AstraZeneca; Speakers' Bureau(s): AstraZeneca, Genentech; Stockholder: Tesaro/GSK, Clovis

Shannon Westin, MD, MPH
Consulting: TESARO-GSK , Pfizer; Grant: Astra-Zeneca

Brian Slomovitz, MD
Advisory board: Abbvie, AstraZeneca, Circulogene, Clovis, Genentech, GSK, Myriad; Steering committee; Leap-01 (Merck), Ruby (GSK), DUO-E (AZ), EndoMAP (Roche); Consultant: GOG Foundation

 

The SGO 2020 Annual Meeting Webinar Series is generously supported by independent medical education grants from AstraZeneca, Eisai and Merck

 

Series Information
Series Date:
May 15, 2020
CE Submission Instructions
Surgical Innovations in Gynecologic Cancers: Part 1
Surgical Innovations in Gynecologic Cancers: Part 2
Surgical Innovations in Gynecologic Cancers: Part 3
Surgical Innovations in Gynecologic Cancers: Part 4
Slides & Online Materials
Individual topic purchase: Selected
AAPA
Category 1 CME : 1.25
ACCME
AMA PRA Category 1 Credit(s)™: 1.25
Accreditation Council for Pharmacy Education
CEU: 1.25
American Nurses Credentialing Center's Commission on Accreditation
Contact Hour: 1.25
Products
Enduring Webinar & CE Credit
Member: $40.00
Full Price: $60.00